STERIS Fine Traction Device, one unit per box Product Usage: The Fine Traction Device is used...
FDA Device Recall #Z-1786-2013 — Class II — May 20, 2013
Recall Summary
| Recall Number | Z-1786-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 20, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Steris Corporation |
| Location | Mentor, OH |
| Product Type | Devices |
| Quantity | 16 units |
Product Description
STERIS Fine Traction Device, one unit per box Product Usage: The Fine Traction Device is used to provide traction and enable fine adjustments to traction and orientation of the leg during orthopedic procedures.
Reason for Recall
A bearing used in the assembly of the Fine Traction Device did not perform successfully in pre-release reliability testing; a replacement bushing passed reliability testing and was substituted per a change order. The change order authorized use of the substitute bushing in assembly of the Fine Traction Accessory; however, inadvertently the new part was not implemented. During complaint evaluati
Distribution Pattern
USA Nationwide Distribution in the states of CO, KY, LA, VA, and WI. The affected product was also distributed to Canada.
Lot / Code Information
The following serial/lot numbers are affected by this recall: 0404913150, 0404913151, 0404913152, 0404913153, 0408713001, 0408713002, 0408713003, 0408713004, 0408713005, 0408713006, 0409813097, 0409813098, 0409813099, 0409813100, 0410113001, 0410113002, 0410713024, 0410713025, 0410713026, 0410713027, 0410713028, and 0410713029.
Other Recalls from Steris Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0910-2026 | Class II | AMSCO 7053HP Washer/Disinfector Model/Catalog... | Nov 19, 2025 |
| Z-0909-2026 | Class II | AMSCO 7052HP Washer/Disinfector Model/Catalog ... | Nov 19, 2025 |
| Z-2178-2025 | Class II | Dual Flat Panel Monitor (DFPM) accessories for ... | Jun 23, 2025 |
| Z-2177-2025 | Class II | Dual Flat Panel Monitor (DFPM) accessories for ... | Jun 23, 2025 |
| Z-1361-2026 | Class II | Barco MNA with the HexaVue IP Integration Syste... | May 23, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.